A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.
Division
Far West
Hospital
MountainView Hospital
Document Type
Case Report
Publication Date
11-28-2021
Keywords
2-fluorodeschloroketamine, Novel psychoactive substances, ketamine
Disciplines
Emergency Medicine
Abstract
Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use presenting after insufflation of 2-FDCK, with subsequent confirmation of metabolites in the patient's urine. A 28-year-old man presented to the Emergency Department in a dissociated state. He recovered well with supportive care, and described during interview his experience of substance use including the novel psychoactive substance 2-FDCK. A urine sample was sent for analysis and 2-FDCK metabolites were isolated. This case is concerning because 2-FDCK is a relatively new agent that has not yet been reported in the United States. It is easy to obtain over the internet and has significant abuse potential.
Publisher or Conference
Journal of Psychoactive Drugs
Recommended Citation
Domanski K, Fleming SW, Maag H, et al. A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis [published online ahead of print, 2021 Nov 28]. J Psychoactive Drugs. 2021;1-5. doi:10.1080/02791072.2021.2006373